The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Glucose Intolerance, Insulin Resistance, and Pathological Features of Alzheimer Disease in the Baltimore Longitudinal Study of Aging
Open accessAbstract
IMPORTANCE: Peripheral glucose homeostasis has been implicated in the pathogenesis of Alzheimer disease (AD). The relationship among diabetes mellitus, insulin, and AD is an important area of investigation. However, whether cognitive impairment seen in those with diabetes is mediated by excess pathological features of AD or other related abnormalities, such as vascular disease, remains unclear. OBJECTIVE: To investigate the association between serial measures of glucose intolerance and insulin resistance and in vivo brain β-amyloid burden, measured with carbon 11–labeled Pittsburgh Compound B (11C-PiB), and AD pathology at autopsy. DESIGN: Scores calculated from the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) and Braak criteria were correlated with measures of hyperglycemia, hyperinsulinemia, glucose intolerance, and insulin resistance in 197 participants who underwent autopsy after death and who had undergone 2 or more oral glucose tolerance tests (OGTT) using grouped analyses and a continuous mixed-models analysis. The same measures of glucose intolerance and insulin resistance were also correlated with brain 11C-PiB retention in an additional 53 living subjects from the Baltimore Longitudinal Study of Aging neuroimaging study. SETTING: Prospective, serially assessed cohort of community-dwelling subjects. PARTICIPANTS: Cohort 1 consisted of 197 participants enrolled in the Baltimore Longitudinal Study of Aging who had 2 or more OGTTs during life and a complete brain autopsy after death. Cohort 2 consisted of 53 living subjects who had 2 or more OGTTs and underwent brain 11C-PiB positron emission tomography. EXPOSURES: Autopsy and 11C-PiB positron emission tomography. MAIN OUTCOMES AND MEASURES: The correlation of brain markers of AD, including CERAD score, Braak score, and 11C-PiB retention, with serum markers of glucose homeostasis using grouped and continuous mixed-models analyses. RESULTS: We found no significant correlations between measures of brain AD pathology or 11C-PiB β-amyloid load and glucose intolerance or insulin resistance in subjects who had a mean (SD) of 6.4 (3.2) OGTTs during 22.1 (8.0) years of follow-up. Thirty subjects with frank diabetes mellitus who received medications also had AD pathology scores that were similar to those of the cohort as a whole. CONCLUSIONS AND RELEVANCE: In this prospective cohort with multiple assessments of glucose intolerance and insulin resistance, measures of glucose and insulin homeostasis are not associated with AD pathology and likely play little role in AD pathogenesis. Long-term therapeutic trials are important to elucidate this issue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“many studies have failed to establish a relationship between systemic insulin resistance or type 2 diabetes and molecular symptoms of neurodegenerative diseases 142”
From Intranasal insulin (2021) · cites this paper as [142]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Self-citationLinear Mixed Models for Longitudinal Data
Verbeke, G. (1997) · Lecture Notes in Statistics · doi:10.1007/978-1-4612-2294-1_3 · Cited by 3,506
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Amyloid Precursor Protein Processing and Alzheimer's Disease
O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061
Self-citationTalbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871
Cited by
Sorted by citations
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Arnold, S. E., Arvanitakis, Z., Macauley-Rambach, S. L., Koenig, A. M., Wang, H.-Y., Ahima, R. S., Craft, S., Gandy, S., Buettner, C., Stoeckel, L. E., et al. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.185 · Cited by 1,597
Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans
Kullmann, S., Heni, M., Hallschmid, M., Fritsche, A., Preissl, H. T., & Häring, H. (2016) · Physiological Reviews · doi:10.1152/physrev.00032.2015 · Cited by 654
Biessels, G. J., Strachan, M. W. J., Visseren, F. L. J., Kappelle, L. J., & Whitmer, R. A. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70088-3 · Cited by 578
Hippocampal insulin resistance and cognitive dysfunction
Biessels, G. J., & Reagan, L. P. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn4019 · Cited by 550
Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
Barrett, E. J., Liu, Z., Khamaisi, M., King, G. L., Klein, R., Klein, R., Hughes, T. M., Craft, S., Freedman, B. I., Bowden, D. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01922 · Cited by 537
Evidence for brain glucose dysregulation in Alzheimer's disease
An, Y., Varma, V. R., Varma, S., Casanova, R., Dammer, E. B., Pletniková, O., Chia, C. W., Egan, J. M., Ferrucci, L., Troncoso, J. C., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.09.011 · Cited by 522
Self-citationVerdile, G., Keane, K. N., Cruzat, V. F., Medic, S., Sabale, M., Rowles, J., Wijesekara, N., Martins, R. N., Fraser, P. E., & Newsholme, P. (2015) · Mediators of Inflammation · doi:10.1155/2015/105828 · Cited by 509
Craft, S., Raman, R., Chow, T. W., Rafii, M. S., Sun, C.-K., Rissman, R. A., Donohue, M. C., Brewer, J. B., Jenkins, C., Harless, K., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1840 · Cited by 389
Type 2 diabetes mellitus and biomarkers of neurodegeneration
Moran, C., Beare, R. J., Phan, T. G., Bruce, D. G., Callisaya, M. L., & Srikanth, V. K. (2015) · Neurology · doi:10.1212/wnl.0000000000001982 · Cited by 298
The role of type 2 diabetes in neurodegeneration
Verdile, G., Fuller, S. J., & Martins, R. N. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.008 · Cited by 290
Insulin resistance predicts brain amyloid deposition in late middle‐aged adults
Willette, A. A., Johnson, S. C., Birdsill, A. C., Sager, M. A., Christian, B., Baker, L. D., Craft, S., Oh, J. M., Statz, E. H., Hermann, B. P., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.03.011 · Cited by 267
A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health status
Sood, S., Gallagher, I. J., Lunnon, K., Rullman, E., Keohane, A., Crossland, H., Phillips, B. E., Cederholm, T., Jensen, T., van Loon, L. J. C., et al. (2015) · Genome biology · doi:10.1186/s13059-015-0750-x · Cited by 240
Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology
Abner, E. L., Nelson, P. T., Kryscio, R. J., Schmitt, F. A., Fardo, D. W., Woltjer, R. L., Cairns, N. J., Yu, L., Dodge, H. H., Xiong, C., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.12.006 · Cited by 233
Is Alzheimer’s disease a systemic disease?
Morris, J. K., Honea, R. A., Vidoni, E. D., Swerdlow, R. H., & Burns, J. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.012 · Cited by 219
Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
Mullins, R. J., Diehl, T. C., Chia, C. W., & Kapogiannis, D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00118 · Cited by 227
Type 2 diabetes as a risk factor for cognitive impairment: current insights
Umegaki, H. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s48926 · Cited by 189
Intranasal Insulin for Alzheimer’s Disease
Hallschmid, M. (2021) · CNS Drugs · doi:10.1007/s40263-020-00781-x · Cited by 188
Roberts, R. O., Knopman, D. S., Cha, R. H., Mielke, M. M., Pankratz, V. S., Boeve, B. F., Kantarci, K., Geda, Y. E., Jack, C. R., Petersen, R. C., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.132647 · Cited by 169
Type 2 diabetes mellitus, brain atrophy, and cognitive decline
Moran, C., Beare, R. J., Wang, W., Callisaya, M. L., Srikanth, V. K., Initiative, A. D. N., Initiative, A. D. N., Weiner, M. W., Aisen, P., Weiner, M. W., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000006955 · Cited by 165
Glucose indices are associated with cognitive and structural brain measures in young adults
Weinstein, G., Maillard, P., Himali, J. J., Beiser, A., Au, R., Wolf, P. A., Seshadri, S. S., & DeCarli, C. S. (2015) · Neurology · doi:10.1212/wnl.0000000000001655 · Cited by 156
Vemuri, P., Knopman, D. S., Lesnick, T. G., Przybelski, S. A., Mielke, M. M., Graff‐Radford, J., Murray, M. E., Roberts, R. O., Vassilaki, M. E., Lowe, V. J., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0244 · Cited by 144
Insulin dysfunction and Tau pathology
Khoury, N. B. E., Gratuze, M., Papon, M.-A., Bretteville, A., & Planel, E. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00022 · Cited by 133
Emerging links between type 2 diabetes and Alzheimer's disease
Sridhar, G. R. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i5.744 · Cited by 123
Mayeda, E. R., Whitmer, R. A., & Yaffe, K. S. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.08.021 · Cited by 129
Insulin resistance in Alzheimer's disease
Diehl, T. C., Mullins, R. J., & Kapogiannis, D. (2016) · Translational research · doi:10.1016/j.trsl.2016.12.005 · Cited by 124
Hallschmid, M. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12934 · Cited by 113
Release of insulin produced by the choroid plexis is regulated by serotonergic signaling
Mazucanti, C. H., Liu, Q.-R., Lang, D., Huang, N., O’Connell, J. F., Camandola, S., & Egan, J. M. (2019) · JCI Insight · doi:10.1172/jci.insight.131682 · Cited by 101
Self-citationThe diabetic brain and cognition
Riederer, P., Korczyn, A. D., Ali, S. S., Bajenaru, O. A., Choi, M. S., Chopp, M., Dobrota, V. Đ., Grünblatt, E., Jellinger, K. A., Kamal, M. A., et al. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1763-2 · Cited by 98
Benedict, C., & Grillo, C. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00215 · Cited by 101
Review: Relationship of type 2 diabetes to human brain pathology
Pruzin, J. J., Nelson, P. T., Abner, E. L., & Arvanitakis, Z. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12476 · Cited by 89
Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art
de la Monte, S. M. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.856877 · Cited by 89
Laws, S. M., Gaskin, S., Woodfield, A., Srikanth, V. K., Bruce, D. G., Fraser, P. E., Porter, T., Newsholme, P., Wijesekara, N., Burnham, S. C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09577-4 · Cited by 98
Midlife insulin resistance, APOE genotype, and late-life brain amyloid accumulation
Ekblad, L. L., Johansson, J. J., Helin, S., Viitanen, M. H., Laine, H. K., Puukka, P. J., Jula, A., & Rinne, J. O. (2018) · Neurology · doi:10.1212/wnl.0000000000005214 · Cited by 89
Insulin resistance and gray matter volume in neurodegenerative disease
Morris, J. K., Vidoni, E. D., Perea, R. D., Rada, R. C., Johnson, D. K., Lyons, K. E., Pahwa, R., Burns, J. M., & Honea, R. A. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.006 · Cited by 87
Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study
van Arendonk, J., Neitzel, J., Steketee, R. M. E., van Assema, D. M. E., Vrooman, H. A., Segbers, M., Ikram, M. A., & Vernooij, M. W. (2022) · Brain · doi:10.1093/brain/awac354 · Cited by 85
Hoscheidt, S. M., Starks, E. J., Oh, J. M., Zetterberg, H., Blennow, K., Krause, R. A., Gleason, C. E., Puglielli, L., Atwood, C., Carlsson, C. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160110 · Cited by 84
Type 2 Diabetes and Cognitive Impairment
Ryan, J. P., Fine, D. F., & Rosano, C. (2014) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988713516543 · Cited by 80
Starks, E. J., O’Grady, J. P., Hoscheidt, S. M., Racine, A. M., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., Puglielli, L., Asthana, S., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150072 · Cited by 82
Li, J., Zhang, Y., Lu, T., Liang, R., Wu, Z., Liu, M., Qin, L., Chen, H., Yan, X., Deng, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1037318 · Cited by 82
The Aging Metabolome—Biomarkers to Hub Metabolites
Sharma, R. B., & Ramanathan, A. (2020) · PROTEOMICS · doi:10.1002/pmic.201800407 · Cited by 81
True or false? Alzheimer’s disease is type 3 diabetes: Evidences from bench to bedside
Peng, Y., Yao, S.-Y., Chen, Q., Jin, H., Du, M., Xue, Y.-H., & Liu, S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102383 · Cited by 84
Melatonin Therapy in Patients with Alzheimer’s Disease
Cardinali, D. P., Vigo, D. E., Olivar, N., Vidal, M., & Brusco, L. I. (2014) · Antioxidants · doi:10.3390/antiox3020245 · Cited by 74
Midlife lipid and glucose levels are associated with Alzheimer's disease
Zhang, X., Tong, T., Chang, A., Ang, T. F. A., Tao, Q., Auerbach, S., Devine, S., Qiu, W. Q., Mez, J., Massaro, J., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12641 · Cited by 65
Zangerolamo, L., Vettorazzi, J. F., Solon, C., Bronczek, G. A., Engel, D. F., Kurauti, M. A., Soares, G. M., Rodrigues, K. S., Velloso, L. A., Boschero, A. C., et al. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111116 · Cited by 65
Insulin signaling: An opportunistic target to minify the risk of Alzheimer’s disease
Pardeshi, R., Bolshette, N. B., Gadhave, K., Ahire, A., Ahmed, S., Cassano, T., Gupta, V. B., & Lahkar, M. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.05.004 · Cited by 67
Metabolic Syndrome and Amyloid Accumulation in the Aging Brain
Gómez, G., Beason‐Held, L. L., Bilgel, M., An, Y., Wong, D. F., Studenski, S. A., Ferrucci, L., & Resnick, S. M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180297 · Cited by 64
Self-citationDiabetes and Alzheimer’s Disease: A Link not as Simple as it Seems
Salas, I. H., & Strooper, B. D. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2690-9 · Cited by 68
Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology
Pruzin, J. J., Schneider, J. A., Capuano, A. W., Leurgans, S. E., Barnes, L. L., Ahima, R. S., Arnold, S. E., Bennett, D. A., & Arvanitakis, Z. (2016) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000172 · Cited by 67
Prediabetes-induced vascular alterations exacerbate central pathology in APPswe/PS1dE9 mice
Ramos‐Rodríguez, J. J., Ortiz-Barajas, O., Gamero-Carrasco, C., de la Rosa, P. R., Infante‐Garcia, C., Zopeque-Garcia, N., Lechuga-Sancho, A. M., & Garcı́a-Alloza, M. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.06.005 · Cited by 61
Task-Induced Brain Activity Patterns in Type 2 Diabetes: A Potential Biomarker for Cognitive Decline
Marder, T. J., Flores, V. L., Bolo, N. R., Hoogenboom, W. S., Simonson, D. C., Jacobson, A. M., Foote, S., Shenton, M. E., Sperling, R. A., & Musen, G. (2014) · Diabetes · doi:10.2337/db13-1783 · Cited by 58
Diabetes and cognitive decline
Bellia, C., Lombardo, M., Meloni, M., Della‐Morte, D., Bellia, A., & Lauro, D. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2021.07.006 · Cited by 59
Neuroimaging and its Relevance to Understanding Pathways Linking Diabetes and Cognitive Dysfunction
Moran, C., Beare, R. J., Phan, T. G., STARKSTEIN, S. E., Bruce, D. G., Mizrahi, R., & Srikanth, V. K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161166 · Cited by 53
Epidemiological Approaches to Understanding the Link Between Type 2 Diabetes and Dementia
Sutherland, G. T., Lim, J., Srikanth, V. K., & Bruce, D. G. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161194 · Cited by 58
van Gils, V., Rizzo, M., Côté, J., Viechtbauer, W., Fanelli, G., Salas‐Salvadó, J., Wimberley, T., Bulló, M., Fernández‐Aranda, F., Dalsgaard, S., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105604 · Cited by 50
Westwood, S., Liu, B., Baird, A. L., Anand, S. N., Nevado‐Holgado, A. J., Newby, D., Pikkarainen, M., Hallikainen, M., Kuusisto, J., Streffer, J. R., et al. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0258-6 · Cited by 50
Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline
Tortelli, R., Lozupone, M., Guerra, V., Barulli, M. R., Imbimbo, B. P., Capozzo, R., Grasso, A. C., Tursi, M., Dio, C. D., Sardone, R., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170153 · Cited by 52
Brain amyloid load and its associations with cognition and vascular risk factors in FINGER Study
Kemppainen, N. M., Johansson, J. J., Teuho, J., Parkkola, R. K., Joutsa, J., Ngandu, T., Solomon, A., Stephen, R., Liu, Y., Hänninen, T., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004827 · Cited by 47
Effects of Exercise on Type 2 Diabetes Mellitus-Related Cognitive Impairment and Dementia
Callisaya, M. L., & Nosaka, K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161154 · Cited by 48
Salas, I. H., Weerasekera, A., Ahmed, T., Callaerts‐Vegh, Z., Himmelreich, U., D’Hooge, R., Balschun, D., Saido, T. C., Strooper, B. D., & Dotti, C. G. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.02.001 · Cited by 46
Non-Alzheimer's disease—related memory impairment and dementia
Arlt, S. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.4/sarlt · Cited by 46
Pablo‐Fernández, E. D., Courtney, R. J., Rockliffe, A., Gentleman, S., Holton, J. L., & Warner, T. T. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12728 · Cited by 43
Diabetes Mellitus and Cognition
Frison, É., Proust‐Lima, C., Mangin, J., Habert, M., Bombois, S., Ousset, P., Pasquier, F., Hanon, O., Paquet, C., Gabelle, A., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012440 · Cited by 42
Guo, C., Zhang, S., Li, J., Ding, C., Yang, Z., Chai, R., Wang, X., & Wang, Z. (2016) · Scientific Reports · doi:10.1038/srep29396 · Cited by 42
Insulin Resistance Predicts Postoperative Cognitive Dysfunction in Elderly Gastrointestinal Patients
He, X., Long, G., Quan, C., Zhang, B., Chen, J., & Ouyang, W. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00197 · Cited by 40
Zhou, X., Yang, Q., Xie, Y., Sun, J., Hu, J. R., Qiu, P., Cao, W., & Wang, S. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.11.002 · Cited by 40
Endosomal-lysosomal dysfunction in metabolic diseases and Alzheimer's disease
de Almeida, M. F., Bahr, B. A., & Kinsey, S. T. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.02.012 · Cited by 42
Wu, M., Cheng, Y., Zhang, R., Han, W., Jiang, H., Bi, C., Zhang, Z., Ye, M., Lin, X., & Liu, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117228 · Cited by 40
Impaired fasting glucose is associated with increased regional cerebral amyloid
Morris, J. K., Vidoni, E. D., Wilkins, H., Archer, A. E., Burns, N. C., Karcher, R. T., Graves, R. S., Swerdlow, R. H., Thyfault, J. P., & Burns, J. M. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.017 · Cited by 40
Hendrix, R. D., Ou, Y., Davis, J. E., Odle, A. K., Groves, T. R., Allen, A. R., Childs, G. V., & Barger, S. W. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.10.001 · Cited by 33
Tian, N., Fa, W., Dong, Y., Liu, R., Liu, C., Liu, K., Mao, M., Zhu, M., Liang, X., Wang, N., et al. (2023) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12426 · Cited by 33
Lu, Y., Jiang, X., Liu, S., & Li, M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00271 · Cited by 34
Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer’s Disease?
Codocedo, J. F., Ríos, J. A., Godoy, J. A., & Inestrosa, N. C. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9201-7 · Cited by 34
Testosterone deficiency, insulin-resistant obesity and cognitive function
Pintana, H., Chattipakorn, N., & Chattipakorn, S. C. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9655-3 · Cited by 33
New cardiovascular targets to prevent late onset Alzheimer disease
Claassen, J. A. H. R. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.022 · Cited by 33
Kangwan, N., Pratchayasakul, W., Kongkaew, A., Pintha, K., Chattipakorn, N., & Chattipakorn, S. C. (2021) · Nutrients · doi:10.3390/nu13093141 · Cited by 35
Shwe, T., Bo‐Htay, C., Ongnok, B., Chunchai, T., Jaiwongkam, T., Kerdphoo, S., Kumfu, S., Pratchayasakul, W., Pattarasakulchai, T., Chattipakorn, N., et al. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111465 · Cited by 32
Diabetes and dementia: Clinical perspective, innovation, knowledge gaps
Savelieff, M. G., Chen, K. S., Elzinga, S. E., & Feldman, E. L. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108333 · Cited by 34
Metformin in the Prevention of Alzheimer's Disease and Alzheimer's Disease Related Dementias
Tahmi, M., & Luchsinger, J. A. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.113 · Cited by 32
Byun, M. S., Kim, H. J., Yi, D., Choi, H. J., Baek, H., Lee, J. H., Choe, Y. M., Sohn, B. K., Lee, J., Lee, Y., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.07.004 · Cited by 31
Association of type 2 diabetes GWAS loci and the risk of Parkinson's and Alzheimer's diseases
Chung, S. J., Kim, M., Kim, J., Ryu, H., Kim, Y. J., Kim, S. Y., & Lee, J. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.10.010 · Cited by 31
Antidiabetic therapies and Alzheimer disease.
Bendlin, B. B. (2019) · PubMed Central · Cited by 30
Pre-Diabetes, but not Type 2 Diabetes, Is Related to Brain Amyloid in Late Middle-Age
Luchsinger, J. A., Palta, P., Rippon, B., Sherwood, G., Soto, L., Ceballos, F., Laing, K. K., Igwe, K. C., He, H., Razlighi, Q. R., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200232 · Cited by 33
Ourry, V., Binette, A. P., St‐Onge, F., Strikwerda‐Brown, C., Chagnot, A., Poirier, J., Breitner, J. C. S., Arenaza‐Urquijo, E. M., Rabin, J. S., Buckley, R. F., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.09.003 · Cited by 30
Yang, H. J., Kwon, D. Y., Kim, M. J., Kang, S., Moon, N. R., Daily, J. W., & Park, S. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0005-6 · Cited by 29
Pratchayasakul, W., Jinawong, K., Pongkan, W., Jaiwongkam, T., Arunsak, B., Chunchai, T., Tokuda, M., Chattipakorn, N., & Chattipakorn, S. C. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1840050 · Cited by 26
Carmichael, O. T., Neiberg, R. H., Dutton, G. R., Hayden, K. M., Horton, E., Pi-Sunyer, F. X., Johnson, K. C., Rapp, S. R., Spira, A. P., & Espeland, M. A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa591 · Cited by 24
Ferreira, L. K., Tamashiro-Duran, J. H., Squarzoni, P., Duran, F., Alves, T. C. T. F., Buchpiguel, C. A., & Busatto, G. F. (2014) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1275 · Cited by 24
Animal Models of Alzheimer’s Disease
Newman, M., Kretzschmar, D., Khan, I., Chen, M., Verdile, G., & Lardelli, M. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00040-1 · Cited by 25
Cortisol: Mediator of association between Alzheimer’s disease and diabetes mellitus?
Notarianni, E. L. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.04.008 · Cited by 23
Pekkala, T., Hall, A., Mangialasche, F., Kemppainen, N. M., Mecocci, P., Ngandu, T., Rinne, J. O., Soininen, H. S., Tuomilehto, J., Kivipelto, M., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200145 · Cited by 23
Carmichael, O. T., Stuchlik, P. M., Pillai, S. R., Biessels, G. J., Dhullipudi, R., Madden‐Rusnak, A., Martin, S., Hsia, D. S., Fonseca, V. A., & Bazzano, L. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02750 · Cited by 23
Noguchi‐Shinohara, M., Yuki-Nozaki, S., Abe, C., Mori, A., Horimoto, M., Yokogawa, M., Ishida, N., Suga, Y., Ishizaki, J., Ishimiya, M., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215153 · Cited by 21
The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults
Ennis, G. E., Betthauser, T. J., Koscik, R. L., Chin, N. A., Christian, B. T., Asthana, S., Johnson, S. C., & Bendlin, B. B. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01180-2 · Cited by 26
Shie, F., Shiao, Y.-J., Yeh, C.-W., Lin, C.-H., Tzeng, T.-T., Hsu, H.-C., Huang, F.-L., Tsay, H.-J., & Liu, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134531 · Cited by 21
Alzarea, E. A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Alexiou, A. T., Papadakis, M., Beshay, O. N., & Batiha, G. E. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-025-08832-6 · Cited by 21
Clusterin as a Potential Biomarker of Obesity-Related Alzheimer’s Disease Risk
Bradley, D. P. (2020) · Biomarker Insights · doi:10.1177/1177271920964108 · Cited by 20
Arunsak, B., Pratchayasakul, W., Amput, P., Chattipakorn, K., Tosukhowong, T., Kerdphoo, S., Jaiwongkum, T., Thonusin, C., Palee, S., Chattipakorn, N., et al. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108470 · Cited by 19
Peripheral Aβ acts as a negative modulator of insulin secretion
Shigemori, K., Nomura, S., Umeda, T., Takeda, S., & Tomiyama, T. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117723119 · Cited by 20
Palix, C., Felisatti, F., Gonneaud, J., Kuhn, E., Mézenge, F., Landeau, B., Chocat, A., Quillard, A., Egret, S., Delarue, M., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.06.004 · Cited by 22
Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer’s Disease
Morris, J. K., Uy, R. A. Z., Vidoni, E. D., Wilkins, H., Archer, A. E., Thyfault, J. P., Miles, J. M., & Burns, J. M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170148 · Cited by 20
Metadata
- Authors
- Thambisetty, M., Metter, E. J., Yang, A., Dolan, H., Marano, C., Zonderman, A. B., Troncoso, J. C., Zhou, Y., Wong, D. F., Ferrucci, L., Egan, J., Resnick, S. M., & O’Brien, R. J.
- Affiliations
- National Institute on Aging (US)
- Johns Hopkins University (US)
- Corresponding author
- O’Brien, Richard J.
- ORCID
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2013-09-01
- Volume
- 70
- Issue
- 9
- Pages
- 1167
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC3934653
- OpenAlex
- W2160143874
- Cited by
- 155
- References
- 37
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 13 · 2023: 9 · 2022: 9 · 2021: 11 · 2020: 14 · 2019: 9 · 2018: 11 · 2017: 20 · 2016: 11 · 2015: 17 · 2014: 19 · 2013: 4
- FWCI
- 12.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (U19AG033655, U01AG033655, P50AG005146, P50AG05146)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- Alzheimer's disease, impaired glucose tolerance, insulin resistance, diabetes mellitus, hyperinsulinemia, hyperglycemia, brain amyloid burden, 11C-PiB PET, autopsy neuropathology, glucose homeostasis, oral glucose tolerance test, Baltimore Longitudinal Study of Aging, vascular disease, cognitive impairment
- MeSH terms
- Aged, Aged, 80 and over, Aging, Alzheimer Disease, Aniline Compounds, Cognition Disorders, Female, Humans, Insulin Resistance, Longitudinal Studies, Male, Prospective Studies, Radionuclide Imaging, Thiazoles, Baltimore, Glucose Intolerance, Benzothiazoles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
